Adventist Health Cancer Care Center Chico — Chico, California

Public research footprint of Adventist Health Cancer Care Center Chico, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Completed

Stopped or withdrawn

Most-studied conditions

Anatomic Stage III Breast Cancer AJCC v8 · Hormone Receptor Positive Breast Carcinoma · Metastatic Malignant Solid Neoplasm · HER2/Neu Negative

Recently updated registry entries

NCT03419234 — Abiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone… (Active Not Recruiting)
NCT02224781 — Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and… (Active Not Recruiting)
NCT02115282 — Exemestane With or Without Entinostat in Treating Patients With Recurrent Hormone… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Adventist Health Cancer Care Center Chico?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.